HEPA News and Press, Hepion Pharmaceuticals Inc. From 04/14/20

Sonnet BioTherapeutics Holdings (NASDAQ: SONN ) +100% . More news on: Sonnet BioTherapeutics Holdings, Inc., MEI Pharma, Inc., NantKwest, Inc., Stocks on the move, Read more ...

Waitr Holdings (NASDAQ: WTRH ) +51%  on expanding into Grocery Delivery. More news on: Waitr Holdings Inc., Innate Pharma S.A., DCP Midstream, LP, Stocks on the move, Read more ...

I view there as being three possible outcomes for the current coronavirus pandemic for the US. The first is that the pandemic overwhelms our healthcare system and shuts down our economy for at least the next six months. I hope this worst case scenario does not occur, but it cannot be dismissed...

Top Penny Stocks Trading Higher Right Now When you’re looking for penny stocks to buy , what are some of the main things you track? Is it news, volume, or maybe it’s simply looking for penny stocks making large moves in price. No matter what you’re looking at understand...

Gainers: Bellerophon Therapeutics (NASDAQ: BLPH ) +407% . More news on: Bellerophon Therapeutics, Inc., Hepion Pharmaceuticals, Inc., Penn National Gaming, Inc., Stocks on the move, , Read more ...

EDISON, NJ / ACCESSWIRE / March 12, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA, "Hepion"), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis ("NASH"), today announced positive find...

Brickell Biotech (NASDAQ: BBI ) +64%  on positive sofpironium bromide data. More news on: Brickell Biotech, Inc., Adesto Technologies Corporation, Stamps.com Inc., Stocks on the move, Read more ...

CRV431 Decreases Collagen and Fibronectin Production from Multiple Cell Types EDISON, NJ / ACCESSWIRE / February 19, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arisin...

EDISON, NJ / ACCESSWIRE / February 12, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis ("NASH"), today announced the advancement to...

Novartis Revenue Jumps but Net Income Falls for Q4 Novartis ( NVS ) posted mixed numbers for its fourth quarter. The company announced strong revenue growth but showed negative impact of higher taxes. Its core operating income for the quarter stood at $3.46 billion, up 11 percent while i...